
Alliance Presents Poster Sessions & Speaks at Symposium During AACR Annual Meeting

The Colorectal Cancer Alliance (Alliance), the leading nonprofit dedicated to ending colorectal cancer (CRC), will present three poster sessions and deliver an oral presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17–22 in San Diego. AACR is one of the world’s premier gatherings for cutting-edge cancer research.
With colorectal cancer rates rising at alarming levels among younger adults, it is now the leading cause of cancer-related death in people under 50. At AACR, the Alliance will highlight innovative, patient-centered initiatives designed to accelerate research, expand access to care, and improve outcomes for all communities.
“Our presence at AACR reflects our commitment to driving meaningful progress that saves lives,” said Michael Sapienza, CEO of the Colorectal Cancer Alliance. “Through initiatives like Project Cure CRC and our community-driven research efforts, we are bringing patients, researchers, and partners together to accelerate discovery, expand access, and ensure that every community benefits from the latest advances.”
Alliance presentations at AACR include:
- Poster #6360: Project Cure CRC: A Patient-Powered Ecosystem Uniting Data, Discovery, and Accelerating Cures for Colorectal Cancer
The Alliance launched Project Cure CRC in 2023 to build a national, patient-powered ecosystem that connects patients, researchers, and partners to accelerate treatment development. By integrating data, advancing research, and fostering collaboration, the initiative aims to improve survival and bring new therapies to patients faster. - Poster #5101: Colorectal Cancer Equity and Impact (CLEAR-CRC): A Community-Based Model for Advancing Biomarker Testing
Through a collaborative partnership across nonprofit, academic, community, and industry stakeholders, the Alliance is leading a prospective study to increase access to comprehensive biomarker testing among underserved populations, helping ensure more patients benefit from precision medicine. - Poster #2387: Advancing Access and Equity in Colorectal Cancer Screening: Insights from the Cycles of Impact Philadelphia Initiative
The Cycles of Impact (COI) Philadelphia Initiative, developed in partnership with Independence Blue Cross and the University of Pennsylvania, addresses disparities in CRC outcomes through targeted outreach, behavioral health support, and community engagement to increase screening and early detection. - Patient Advocate Poster Symposium: Advancing Cancer Research Through Patient and Community Partnerships
Kim Newcomer, Senior Director of Research Programs at the Alliance, will speak about Project Cure CRC, the Alliance’s patient-powered ecosystem that is uniting patients, data and discovery in advancing cancer research and improving outcomes.
For more information on Project Cure CRC, the Alliance’s research initiatives, or to get involved and make a difference, visit AACR Advocacy Partners Pavilion booth #22 or go to colorectalcancer.org/curecrc.
About the Colorectal Cancer Alliance
The Colorectal Cancer Alliance empowers a nation of passionate and determined allies to prevent, treat, and overcome colorectal cancer in their lives and communities. Founded in 1999 and headquartered in Washington, D.C., the Alliance advocates for prevention through initiatives like LEAD FROM BEHIND, magnifies support with BlueHQ, and accelerates research through Project Cure CRC. We are the largest national nonprofit dedicated to colorectal cancer, and we exist to end this disease in our lifetime. For more information, visit colorectalcancer.org.
Media Contact:
Emily Blasi
eblasi@ccalliance.org
(202) 971-9964
Top resources

LEAD FROM BEHIND Campaign with Katie Couric Nominated for Two Webby Awards
Fans are encouraged to vote to help LEAD FROM BEHIND win at vote.webbyawards.com.

Fly deals that give back
Looking for a fun, meaningful way to support the colorectal cancer community? These trusted partners are offering exclusive deals and experiences that support the Colorectal Cancer Alliance.

Where breakthroughs begin: Project Cure CRC spotlight on Dr. Lisa Mielke
hrough Project Cure CRC, the Alliance is fueling bold, early-stage research with the potential to transform colorectal cancer treatment. Dr. Lisa Mielke’s groundbreaking work explores how the gut’s immune system and nerve signaling influence cancer growth—opening the door to new therapeutic approaches, including repurposed existing drugs. This is what’s possible when promising ideas get the support they need to move forward.




